Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manali Rupji

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of the American College of Cardiology|January 18, 2023
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 InfectionEliano P Navarese, Przemysław Podhajski, Paul A Gurbel, et al.
Cancer Research|May 31, 2019
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia ProgressionJennifer L Rabe, Lori Gardner, Rae Hunter, et al.
Head & Neck|December 22, 2022
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilitiesJames R Janopaul-Naylor, Manali Rupji, Rachel A Tobillo, et al.
JACC. Cardiovascular Interventions|June 11, 2021
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVREliano Pio Navarese, Zhongheng Zhang, Jacek Kubica, et al.
Journal of Neuro-Oncology|February 7, 2019
Modulating native GABA<sub>A</sub> receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell deathLaura Kallay, Havva Keskin, Alexandra Ross, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of the American College of Cardiology|January 18, 2023
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 InfectionEliano P Navarese, Przemysław Podhajski, Paul A Gurbel, et al.
Cancer Research|May 31, 2019
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia ProgressionJennifer L Rabe, Lori Gardner, Rae Hunter, et al.
Head & Neck|December 22, 2022
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilitiesJames R Janopaul-Naylor, Manali Rupji, Rachel A Tobillo, et al.
JACC. Cardiovascular Interventions|June 11, 2021
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVREliano Pio Navarese, Zhongheng Zhang, Jacek Kubica, et al.
Journal of Neuro-Oncology|February 7, 2019
Modulating native GABA<sub>A</sub> receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell deathLaura Kallay, Havva Keskin, Alexandra Ross, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Pageof 6